期刊文献+

抗突变型瓜氨酸波形蛋白抗体在幼年特发性关节炎中的临床价值 被引量:3

Clinical Evaluation of Anti-mutated Citrullinated Vimentin Antibody in Juvenile Idiopathic Arthritis
下载PDF
导出
摘要 目的通过检测幼年特发性关节炎(JIA)患者血清中的抗突变型瓜氨酸波形蛋白(MCV)抗体,分析抗MCV抗体与JIA临床表现的关系。方法采用酶联免疫吸附试验(ELISA)检测87例JIA患者和55例非JIA患者的抗MCV抗体,并记录JIA患者的临床指标,分析抗MCV抗体与临床指标的关系。结果 在JIA患者中抗MCV抗体的敏感性和特异性分别为44.8%和98.2%,抗MCV抗体阳性组患者肿胀关节数、压痛关节数和X线关节受累数均明显高于抗MCV抗体阴性组,差异有统计学意义(P<0.05)。结论抗MCV抗体与JIA患者关节受累程度、骨关节侵蚀破坏有关。 Objective To detect anti-mutated citrullinated vimentin(MCV} antibody in patients with juven- ile idiopathic arthritis( JIA } , to evaluate the correlation between anti-MCV antibody and clinical manifestations of JIA. Methods Anti-MCV antibody was detected by enzyme-linked immunosorbent assays { ELISA ) in the serum of 87 JIA patients and 30 patients with other rheumatic diseases and 25 healthy children. The relevance between anti-MCV anti- body and clinical characteristics data was analyzed statistically. Results Anti-MCV antibody had a sensitivity of 44.8% and a specificity of 98.2% in JIA patients. The swollen joint counts, tender joint counts and the number of X-ray involve- ment were significantly higher in anti-MCV positive patients than the anti-MCV negative group ( P 〈 0.05 ). Conclusion Our data suggest that anti-MCV antibody may be correlated with bone erosion in JIA.
出处 《潍坊医学院学报》 2014年第1期18-20,共3页 Acta Academiae Medicinae Weifang
关键词 幼年特发性关节炎 抗突变型瓜氨酸波形蛋白抗体 骨关节侵蚀 Juvenile idiopathic arthritis Anti-mutated citrullinated vimentin Bone erosion
  • 相关文献

参考文献9

  • 1Vossenaar ER, Despres N, Lapuinte E, et al. Rheumatoid arthritis spe- cific anti-Sa antibodies target citmllinated vimentin [ J ]. Arthritis Res Ther,2004,6 (2) : R142 - R150.
  • 2. Bang H, Egerer K, Gauliard A, et al. Mutation and citrullination modi- fies vimcntin to a novel autoantigen for rheumatoid arthritis[ J]. Arthri- tis Rheum,2007,56 ( 8 ) :2503 - 2511.
  • 3Mansour HE, Metwaly KM, Hassan IA, et al. Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, associ- ation with radiologieal damage and axial skeleton affection [ J ]. Clin Med Insights Arthritis Musculoskelet Disord , 2010,3 : 33 - 42.
  • 4Kuna AT, Lamot L, Miler M, et al. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idi- opathic arthritis [ J 1. Clin Chem Lab Med,2009,47 : 1525 - 1530.
  • 5Lindqvist E, Eberhardt K, Bcndtzen K, et al. Prognostic laboratory markers of joint damage in rheumatoid arthritis [ J ]. Ann Rheum Dis, 2005,64 : 196 - 201.
  • 6Scott DL. Prognostic factors in early rheumatoid arthritis[ J]. Rheuma- tology,2000,39 : 124 - 129.
  • 7Snir O,Widhc M, Hermansson M, et al. Antibodies to several citrulli- nated antigens are enriched in the joints of rheumatoid arthritis pa- tients [ J ]. Arthritis Rheum,2010,62:44 - 52.
  • 8Nicaise RP, Grootenboer MS, Bruns A, et al. Antibodies to mutated cit- rullinated vimcntin for diagnosing rheumatoid arthritis in anti-CCP- negative patients and for monitoring infliximab therapy [ J 1. Arthritis Res Ther ,2008 ,10 :R142.
  • 9Syversen SW, Goll GL, van der Heijde D, et al. Prediction of radio- graphic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin:resuhs from a 10-year prospec- tive study[ J]. Ann Rheum Dis,2010,69:345 - 351.

同被引文献31

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部